STROKE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2020-02-28 1480aa6cm65(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2020.2.12投，2.18拒

242 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2019-11-27 12536e50m64暂无昵称

请问接受吗139****2357(暂无匿称) 2019-06-10 发表::
接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表:
接受病例报道吗

139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗

262 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2019-06-10 1e0d1c92m57(暂无匿称)

接受病例报道吗

280 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2019-03-23 1e0d1c92m57(暂无匿称)

我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表:
接收病例报告吗？

Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？

351 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2018-10-27 Chi Lin(林驰)

外审了，机率还是大的！weilinjie 2018-10-25 发表::
外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表:
外审了，被录用的机率多大

weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大

440 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2018-09-17 123de756m76暂无昵称

请问该杂志版面费多少呢？

392 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2018-07-22 122ce9c9m82(暂无昵称)

请问多久接收啦？Dr.？？？ 2017-08-21 发表::
投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表:
投了一篇meta分析，希望好运

Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运

446 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2017-09-26 Dr.？？？

一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表::
投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表:
投了一篇meta分析.希望好运

Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运

464 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2017-08-21 Dr.？？？

投了一篇meta分析，希望好运

487 0

[GetPortalCommentsPageByObjectIdResponse(id=585567, encodeId=703658556eff, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.2.12投，2.18拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:15:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580574, encodeId=98625805e402, content=请问接受吗139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗139****2357(暂无匿称) 2019-06-10 00:00:00 发表: 接受病例报道吗, beContent=139****2357(暂无匿称) 2019-06-10 发表:: 接受病例报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572087, encodeId=8fa95e208756, content=接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Mon Jun 10 00:00:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568502, encodeId=e7ab5685024d, content=我也想知道接收病例报告吗Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, beContent=Alee 2017-05-18 21:36:00 发表: 接收病例报告吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=834c1932461, createdName=1e0d1c92m57(暂无匿称), createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562437, encodeId=c50a56243e90, content=外审了，机率还是大的！weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大weilinjie 2018-10-25 00:00:00 发表: 外审了，被录用的机率多大, beContent=weilinjie 2018-10-25 发表:: 外审了，被录用的机率多大, objectType=tool_impact_factor, channel=null, level=null, likeNumber=440, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/25/e2c98c2fc0cfca7709917280bee68f44.jpg, createdBy=76492397819, createdName=Chi Lin(林驰), createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561127, encodeId=b7fc56112e8d, content=请问该杂志版面费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd4a2443846, createdName=123de756m76暂无昵称, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559476, encodeId=b85d5594e64e, content=请问多久接收啦？Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运Dr.？？？ 2017-08-21 00:00:00 发表: 投了一篇meta分析，希望好运, beContent=Dr.？？？ 2017-08-21 发表:: 投了一篇meta分析，希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c692360672, createdName=122ce9c9m82(暂无昵称), createdTime=Sun Jul 22 00:00:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547621, encodeId=de4654e62161, content=一审34天.给了大修.期望好运Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运Dr.??? 2017-08-21 00:00:00 发表: 投了一篇meta分析.希望好运, beContent=Dr.??? 2017-08-21 发表:: 投了一篇meta分析.希望好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Tue Sep 26 00:00:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545719, encodeId=7032545e194e, content=投了一篇meta分析，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0c32045478, createdName=Dr.？？？, createdTime=Mon Aug 21 00:00:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545368, encodeId=bdaf545368ff, content=请问怎么订阅李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, beContent=李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b71721522, createdName=华人, createdTime=Thu Aug 10 00:00:00 CST 2017, time=2017-08-10, status=1, ipAttribution=)]

2017-08-10 华人

请问怎么订阅李斗斗 2016-03-16 23:03:00 发表:
请问在哪里可以订阅

李斗斗 2016-03-16 23:03:00 发表: 请问在哪里可以订阅

469 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务